ASHM, January 2025 Summary of Australian recommendations for anal cancer screening in PLHIV While uncommon in the general population, the incidence of anal squamous cell carcinoma (ASCC) is increasing, and certain groups, including people living with HIV (PLHIV) are disproportionately affected. While anal cancer can affect people of all ages, unlike cervical cancer, rates do not start rising...
Ylva Odenbring & Lisa Lindén (2023) Gender, sex and equal health: school nurses’ strategies and experiences of including boys in the HPV vaccination programme in Swedish primary schools, Sex Education, 23:5, 617-630, DOI: 10.1080/14681811.2022.2106959 Abstract: Since autumn 2020, boys in the fifth year of school (11-year-old students) in Sweden have been offered human papillomavirus (HPV)...
Immunisation Coalition, February 2023 With the latest facts about Human Papilloma Virus (HPV) and vaccination, this webinar covers everything you need to know about the disease and available vaccines. A Certificate of attendance will be issued to attendance for 50 minutes or more. The event will be recorded and available on our website after the event. This event is not accredited with RACGP or...
Kirby Institute (UNSW) – released Thursday 8 December 2022 Data released last month by the Kirby Institute at UNSW Sydney reveals how the COVID-19 pandemic has impacted testing and diagnoses of sexually transmissible infections (STI) in Australia. The report titled HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report shows that in 2021 there...
Positive Life in partnership with Femfatales, the National Network of Women Living with HIV, 2018 All women and anyone with a cervix in Australia, both HIV-positive and HIV-negative, are invited to take an online, anonymous survey about awareness of HPV and related cancers. Positive Life NSW in partnership with Femfatales, the National Network of Women Living with HIV, has developed a survey to...
AJP, 9th Oct 2017
The Government has announced free access for young people to the improved HPV vaccine.
From 2018, Gardasil 9, which protects against nine HPV strains (up from four) will be offered through school-based immunisation programs to all 12 to 13-year-old boys, and girls in years seven or eight.
Read more of Gardasil 9 now on the National Immunisation Program